Roadshow
Cell Reveal Series – CR6
capture specific / abnormal cells with semiconductor biochips
▸ High sensitivity
▸ High capture rate
Applications and Benefits
▸ Non-invasive disease monitoring
▸ Biological research
▸ Drug screening
▸ Early pathological diagnosis
Cell Reveal Series – CR6
capture specific / abnormal cells with semiconductor biochips
▸ High sensitivity
▸ High capture rate
Applications and Benefits
▸ Non-invasive disease monitoring
▸ Biological research
▸ Drug screening
▸ Early pathological diagnosis
Cell Reveal Semiconductor Biochip
▸ Etching method was applied to
obtain micro pillar arrays on 1μm thick
▸ Anemone-like tentacles
CMS Series
The world′s 1st system for liquid biopsy and tissue sections
▸ Multifunctional Micro Scanner
▸ AI Analysis Tool
Applications and Benefits
▸ Faster, more accurate, reduced human errors, data consistency
▸ Traditional pathology to A.I. digital pathology
▸ Tumor microenvironment
▸ Liquid biopsy (e.g., immune disease analysis
CMS series- Cyto Multi Scanner System
1st digital pathology scanner supporting transmitted light, fluorescence, and CTC biochip.
▸ Automatically complete cycle acquisition of multiple staining.
▸ Integrate multi-color imaging and analysis with Cell Analysis Tool (CAT) software.
CMS series- Cell Analysis Tool (CAT)
Automatically find the location of all target cells.
▸ Reducing false positives and improving accuracy Integrate fully automated machinery and precision optics.
▸ Analyzes millions to billions of image pixels containing information about color, absolute coordinates, and grayscale.
Nano CAST™ CTC -Cancer Detection Procedure
Cell Reveal Series + CMS Series
- Established 2015
- Company CytoAurora Biotechnologies, Inc.
- Telephone 03-6105568
- Email contact@cytoaurora.com
- Address 11F.-1, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302041, Taiwan (R.O.C.)
CytoAurora Biotechnology combines semiconductor, artificial intelligence and biomedicine and other cross-field technologies to develop its own patented technology. The company is dedicated to advancing single-cell research and application platforms, enhancing the development of scientific research and clinical studies.